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Recombination can assort polymorphic alleles to increase diversity in the HIV-1 population. To better
understand the recombination potential of subtype A HIV-1, we generated viruses containing sequences
from two variants circulating in Russia and analyzed the polymerase gene (pol) of the recombinants after
one round of HIV-1 replication using single-genome sequencing. We observed that recombination
occurred throughout pol and could easily assort alleles containing mutations that conferred resistance to
currently approved antivirals. We measured the recombination rate in various regions of pol including a
G-rich region that has been previously proposed to be a recombination hot spot. Our study does not
support a recombination hot spot in this G-rich region. Importantly, of the 58 proviral sequences
containing crossover event(s) in pol, we found that each sequence was a unique genotype indicating that
recombination is a powerful genetic mechanism in assorting the genomes of subtype A HIV-1 variants.
Published by Elsevier Inc.
Introduction
HIV-1 undergoes frequent recombination, which can assort
polymorphic alleles in the viral population to generate new
variants. Increased variation in the viral population improves the
probability of survival of the population upon changes in selection
pressures in the host. HIV-1 recombination has been shown to
generate variants that escape the host immune response (Streeck
et al., 2008) and to produce viruses that have increased resistance
to antiviral drugs (Kellam and Larder, 1995; Moutouh et al., 1996).
Hence, recombination is a powerful genetic mechanism for HIV-1
to survive the ever-changing host environment.
Although the full-length HIV-1 RNA genome contains all of the
genetic information required for viral replication, HIV-1 packages
two copies of the viral RNA genome into one virion (Chen et al.,
2009). It has long been speculated that one of the selective
advantages for retroviruses to package two copies of viral RNA is
to increase the assortment of genetic information by recombina-
tion (Temin, 1991). Frequent retroviral recombination occurs dur-
ing DNA synthesis when virally encoded reverse transcriptase uses
a portion of each copackaged RNA as a template (Hu and Temin,
1990a). The resulting DNA is mosaic in its genetic composition and
contains portions of its sequence from each copackaged viral RNA
molecule (Hu and Temin, 1990a; Hu and Temin, 1990b). Although
recombination can occur in all HIV-1 particles, genetically differ-
ent recombinants are generated from particles containing gen-
etically distinct RNAs, which are referred to as heterozygous
particles. Heterozygous particles are produced from cells co-
infected with more than one virus and when RNAs derived from
two different proviruses are copackaged during the virion assem-
bly process. Although recombination can occur in homozygous
particles, which contain two copies of RNA derived from the same
provirus, the resulting recombinants have the same genotype as
the parental virus and cannot be identiﬁed.
Recombination can occur throughout the viral genome; how-
ever, several regions of the HIV-1 genome have been proposed to
be recombination hot spots (Galetto et al., 2006, 2004; Piekna-
Przybylska et al., 2013; Dykes et al., 2004). One of the best deﬁned
hot spots is located in the envelope (env) gene (Galetto et al., 2006,
2004). It has been shown that a particular RNA structure promotes
recombination in this region, and destroying the structure reduces
the recombination rate. Recently, a region near the central poly-
purine tract (cPPT) has been proposed to be a recombination hot
spot (Piekna-Przybylska et al., 2013). It was hypothesized that the
G-rich region can form an intermolecular G-quartet, thereby
facilitating RNA dimerization and recombination. As most of the
experimental data supporting this hypothesis was based on
studies performed using puriﬁed proteins and RNA, testing the
recombination property of this region in vivo will be informative
to conﬁrm this hypothesis.
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Currently, the predominant HIV-1 subtype circulating in Russia
is subtype A (Smolskaya et al., 2006; Thomson et al., 2009).
Although current studies suggest that only low levels of drug-
resistant variants are transmitted, it has been predicted that drug
resistance may become a major issue in Russia in the future
because of the irregular drug supply and possible low adherence
to therapy (Bobkova, 2013). Therefore, it is important to under-
stand how recombination can assort subtype A sequences, thereby
generating multi-drug resistant viruses. A majority of the recom-
bination studies on HIV-1 are performed using laboratory stains of
subtype B variants (Galetto et al., 2004; Dykes et al., 2004; Baird
et al., 2006; Levy et al., 2004; Sakuragi et al., 2008; Rhodes et al.,
2003, 2005; Archer et al., 2008; Onafuwa et al., 2003; Zhuang
et al., 2002; Jetzt et al., 2000). In this report, we sought to deﬁne
the recombination potential of subtype A HIV-1. Because Russian
subtype A molecular clones were not available to us, we synthe-
sized the gag-pol regions based on published sequences (Thomson
et al., 2007; Galkin et al., 2012) from two subtype A isolates, one
from Moscow and one from St. Petersburg. We then replaced a
large portion of the sequences from our subtype B HIV-1 con-
structs (Rhodes et al., 2005) with synthesized subtype A sequences
and studied recombination events occurring in one round
of replication. Using a green ﬂuorescent protein (GFP) reporter
system, we found that subtype A HIV-1 recombines frequently at a
rate similar to that of subtype B and subtype C HIV-1. We have also
analyzed recombination events within subtype A pol gene, and
found that recombination can frequently assort polymorphisms in
the pol gene, including those that could confer antiviral drug
resistance. Additionally, we have analyzed recombination events
near the cPPT and the G-rich region, where the proposed hot spot
is located; our results do not support the presence of a recombina-
tion hot spot in this region.
Results
Constructs used to study subtype A HIV-1 recombination
To study recombination between two subtype A HIV-1 variants,
we generated viral constructs containing two distinct Russian
subtype A sequences based on published sequences EF545108
and FJ864679 (Thomson et al., 2007; Galkin et al., 2012). For each
isolate, a portion of the viral genome from the primer binding site
to the end of the pol gene was synthesized and used to replace
the corresponding subtype B HIV-1 sequences in the previously
described NL4-3-based vectors H0 and T6 (Rhodes et al., 2005),
generating EF-H0 and FJ-T6, respectively. The general structures of
EF-H0 and FJ-T6 are shown in Fig. 1A. Brieﬂy, these vectors express
Gag/Gag-Pol, Tat, and Rev, and contain all cis-acting elements
essential for virus replication. Additionally, EF-H0 carries two
marker genes in nef, hsa followed by an internal ribosome entry
site (IRES) and an inactivated gfp gene with a frameshift mutation
at the 50 end of the gene. Construct FJ-T6 also carries two markers
in nef, thy followed by IRES and an inactivated gfp gene, which
contains a frameshift mutation at the 30 end of the gene. Neither
EF-H0 nor FJ-T6 contains a functional gfp gene; however, if
recombination occurs within the region between the two inacti-
vating mutations, functional gfp gene can be restored (Fig. 1A).
Experimental system used to study HIV-1 recombination
To study recombination in one round of HIV-1 replication, we
generated producer cells that contain one copy of EF-H0 and FJ-T6
proviruses (Fig. 1B). Brieﬂy, human 293T cells were sequentially
infected at a low MOI with EF-H0- and FJ-T6-derived viruses
pseudotyped with VSV-G. Dually infected cells were enriched by
repeated sorting until 497% of the cells expressed both HSA and
Thy markers (Fig. 2A); the resulting producer cells represent a pool
of cells containing 484,000 independent infection events.
Because neither construct contains a functional env, these produ-
cer cells only generate noninfectious viral particles.
To study recombination in one round of HIV-1 replication, the
producer cells were transfected with a plasmid that expressed
CCR5-tropic HIV-1 Env from the AD8 strain. Viruses were har-
vested and used to infect target Hut/R5 cells, a CCR5-expressing T
cell line. The target cells were processed and analyzed by
ﬂow cytometry 72 h post-infection. The proportions of infected
cells were determined by HSA or Thy expression, whereas cells
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Fig. 1. Experimental system used to study HIV-1 recombination. (A) General
structures of the HIV-1 constructs EF-H0 and FJ-T6. Asterisks indicate inactivating
mutations in the gfp gene; a functional gfp gene can be reconstituted by template
switching events during reverse transcription. (B) Experimental procedure used to
study recombination events.
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containing recombinants were identiﬁed by GFP expression
(Fig. 2B). Human 293T cells do not express CD4, which is required
for the AD8-Env-mediated HIV-1 entry; therefore, reinfection
cannot occur in the producer cells, and the recombination events
measured in this system are from one round of HIV-1 replication.
Recombination studied using gfp gene reconstitution and the
approach employed to sequence pol gene
Results from three independent infection experiments are
summarized in Table 1. We found that approximately 5.7% of the
infected Hut/R5 cells expressed GFP. Our previous measured gfp
reconstitution rate between two subtype B viruses was 6.9%
(Rhodes et al., 2005), and between two subtype C viruses was
7.1% (Chin et al., 2005). The 5.7% rate for subtype A does not
deviate far from subtype B or C, but is slightly lower. A likely cause
of the slightly lower rate is that the EF strain has a 1-nt deletion in
its dimerization initiation signal (DIS); the DIS for EF is GTGCC and
FJ is GTGCAC. We have previously shown that imperfect base-
pairing of the DIS can reduce the proportion of heterozygous
virions in the viral population, thereby decreasing the recombina-
tion rate (Chen et al., 2009, 2005).
To better understand the recombination pattern in the subtype
A HIV-1 genome, we analyzed pol from the viral genomes in GFPþ
cells. As both parental genomes, EF-H0 and FJ-T6, encode a mutant
gfp gene, only recombinants generated from heterozygous parti-
cles that underwent a recombination event in gfp during reverse
transcription can encode a functional gfp gene. Most of the proviral
genomes in the GFPþ population are from such heterozygous
particles.
To ensure that a sufﬁcient number of independent recombina-
tion events were studied, we infected a large number of target
cells (44107 cells) with low MOIs (0.07–0.05) of viruses
generated from the producer cell line. Two infection experiments
were performed; in each experiment 41.5105 independently
infected GFPþ cells were generated and enriched by cell sorting.
Total DNAs were isolated from these infected cells and subjected
to single genome sequencing (Kearney et al., 2008) using primers
that ﬂanked pol. Brieﬂy, DNA samples were serially diluted and
used as templates for PCR ampliﬁcation. A ﬁnal dilution that
yielded a positive ampliﬁcation in less than one in four reactions
was used to ensure that the majority of ampliﬁed genomes were
derived from a single provirus (Kearney et al., 2008).
Determining the recombination junctions in the subtype A HIV-1 pol
gene revealed diverse recombination patterns generated during one
round of viral replication
We have ampliﬁed and analyzed 69 pol gene sequences from
the two pools of GFPþ cells using single-genome sequencing. In
each sequence, we analyzed a 2870-nt segment, from nt 26 of the
protease (PR)-coding region to the stop codon of integrase (IN)
gene. The nucleotide sequences of EF and FJ in the pol gene contain
93% homology. Within the 2870-nt region analyzed, there are 148
single nucleotide sequence differences (polymorphic sites)
between these two molecular clones scattered throughout the
pol gene. The distances between the polymorphic sites range from
0nt to 107nt with an average of 18nt and a median of 11nt (Fig. 3).
Because substitution mutation can occur during reverse transcrip-
tion of the viral genome, only events that contain more than one
contiguous single nucleotide change are identiﬁed as recombina-
tion events. Most of the recombination events generate more than
one nucleotide change and are not affected by this criterion.
However, this criterion shortens the sequences that we can
analyze because recombination events at the two ends of the
sequences are not counted. For example, a crossover event
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Fig. 2. Representative results of ﬂow cytometry analyses. (A) Analyses of the
producer cell line. Left panel shows that 497% of cells express HSA and Thy
markers, encoded by the two parent proviruses. Right panel shows that the
producer cells lack GFP expression. (B) Analyses of target Hut/R5 cells after
infection. Left panel shows cells expressing HSA or Thy, whereas the right panel
shows cells expressing GFP.
Table 1
Recombination rate determined by reconstitution of a functional GFP.
Exp. Total
live
Total infected
cells
HSAþ
cells
Thyþ
cells
GFPþ
cells
GFPþ in infected
cells (%)
1 643,647 23,359 15,625 7860 1331 5.7
2 775,250 50,322 35,898 15,808 2889 5.7
3 968,702 43,145 23,957 19,913 2468 5.7
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Fig. 3. Distribution of distance between polymorphic sites in the target pol region
and between sites in which crossover was observed.
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between the ﬁrst and the second polymorphic site only yields one
nucleotide difference, which is not counted. As a result, we only
measured the frequency of crossover events starting from the
second polymorphic site.
We aligned the reads obtained from the single-genome
sequencing reactions with the two parental genomes and identi-
ﬁed the crossover junctions. There are 147 regions between the
148 polymorphic sites; after eliminating the two regions at the
ends (see previous paragraph), there are 145 potential crossover
regions. Of these, we observed recombination in 65 different
regions. The shortest distance between two markers in which we
have detected recombination is 2nt, whereas the longest is 107nt;
with an average of 32nt and a median of 26nt. The distribution of
the nucleotide lengths between markers is shown in Fig. 3. The
distribution of distances between polymorphic sites in which
crossover were observed is similar to that of the general distribu-
tion, indicating that recombination were detected among poly-
morphic sites of varying distances.
Of the 69 sequences, 11 sequences do not have a crossover
event in the pol gene, whereas 15, 14, and 16 sequences had 1, 2,
and 3 crossover events in the pol gene, respectively (Table 2). Of
the sequences that had multiple crossovers in the pol gene, 5, 3,
and 3 sequences had 4, 5, and 6 crossovers, respectively. Addi-
tionally, one sequence had 7 and another had 9 crossovers in their
pol genes. Altogether, there were 160 crossover events in the 69
sequences analyzed.
The recombination patterns of the 58 sequences that had
observed crossover events in pol are shown in Fig. 4. Each of the
58 recombinants had a distinct genotype; none of the 58
sequences were identical. These results demonstrate that the
alleles in the two viral genomes are efﬁciently assorted during
one round of viral replication to generate a very large array of
genotypes.
The distribution of the recombination crossover junctions in subtype
A pol gene
The polymorphic markers are distributed throughout the 2.8-
kb sequence with varied distances between the markers. To
calculate the recombination rate, we ﬁrst identiﬁed the number
of recombination events observed in a given region between two
markers in the 69 sequenced genomes. We then generated the
recombination rate per nucleotide per genome by dividing the
observed events by 69 (genome sequenced) and then by the
number of nucleotides between the two markers. Using the
recombination rate of each nucleotide, we summed up the rates
for 25 individual nucleotides to generate the recombination rates
per 25-nt segment.
The recombination rate of each 25-nt region in the subtype A
pol gene is shown in Fig. 5. Recombination is observed throughout
the pol gene, including the regions that code for PR, RT, and IN. The
recombination rate at each 25-nt region varied from undetectable
to 8%, with an average of 2.1% (standard deviation 1.5%). The cPPT
is located at nt 2507 to 2521 whereas the G-rich sequence
proposed to form G-quartets is located between nt 2516 and
2544 (Fig. 5). Recombination rates of the region including the
cPPT and G-rich region are 3.7%, approximately one standard
deviation above the average values.
To further examine whether recombination hot spot(s) can be
identiﬁed in the pol gene, we analyzed the relationship between
the number of crossover events observed between two poly-
morphic sites and the number of nucleotides between these two
sites. There are 145 regions between polymorphic sites in the
analyzed region; however, some polymorphic sites are immedi-
ately adjacent to each other with 0 nucleotide distance between
them. None of the crossover events occurred in regions with
0 nucleotide distance and these regions were excluded to facilitate
the statistical analysis. Hence, we analyzed 133 regions between
polymorphic sites in which the distances varied between 1 nt to
117 nt, and the crossover events observed in each region varied
from 0 to 11. We then performed a loglinear analysis to test the
relationship between the number of crossover events that
occurred between two polymorphic sites and the numbers of
nucleotides separating them. The likelihood ratio we obtained is
130.1 with 132 degrees of freedom (p¼0.53), indicating that the
number of crossover events and the number of nucleotides
separating them are proportional, i.e., homogeneous. Therefore,
our results do not support the presence of a recombination hot
spot in the pol gene, including the previously proposed G-rich
region.
Taken together, we observed frequent HIV-1 recombination
throughout the pol gene and in the gfp marker gene. These results
afﬁrm that frequent recombination can occur between subtype A
HIV-1 to assort polymorphic sequences and increase diversity of
the viral population.
Discussion
Mutation and recombination during reverse transcription of
the viral RNA genome are two major mechanisms that generate
diversity in HIV-1 populations. Genetic diversity in the viral
population provides the possibility for some variants to survive
in the ever-changing environment, such as challenges from the
host immune response and antiviral treatments. To better under-
stand how frequently novel genotypes can be generated by
recombination in subtype A HIV-1, we have analyzed a 2.8-kb
region encompassing almost the entire pol gene. Our results
revealed that of the 58 proviral sequences that had crossover
events, 58 different novel genotypes were generated within one
round of viral replication (Fig. 4). As crossover events are observed
throughout the pol gene, our data further demonstrated the power
of this genetic mechanism to assort sequences and generate viral
diversity.
Currently, there are 25 FDA-approved antiviral drugs for HIV-1,
most of which target the pol gene products including PR, RT, and
IN. At this time, there are identiﬁed mutations in HIV-1 genomes
that can confer resistance to each of these antivirals. Recombina-
tion between variants can assort mutations to generate a more
resistant virus or a virus that is resistant to more than one antiviral
drug (Kellam and Larder, 1995; Moutouh et al., 1996). To examine
how recombination can affect the generation of multi-drug resis-
tant subtype A HIV-1, we analyzed our results to determine the
probability that dual-drug resistant virus will be generated from
two viruses each of which is resistant to one drug. For this
purpose, we analyzed three codons in the viral sequences that
play important roles in conferring resistance to antiviral treat-
ments, namely the nucleotides that encode I84 in PR, Q151 in
reverse transcriptase (RT), and Q148 in IN (shown as solid squares
in Fig. 4). Mutations in I84, Q151, and Q148 can confer resistance to
multiple PR, RT, and IN inhibitors, respectively. The distance
between the I84 in PR and Q151 in RT is 0.5 kb whereas the
distance between Q151 in RT and Q148 in IN is 1.7 kb. Analyzing
the recombinant genotypes showed that, of the 58 recombinants,
19 had crossover events between the I84 and Q151; because of
these events, the I84 and Q151 alleles of 15 recombinants were
Table 2
Single-genome sequencing of the pol region.
No. crossover. 0 1 2 3 4 5 6 7 8 9 Total
No. of sequence 11 15 14 16 5 3 3 1 0 1 69
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Fig. 4. Patterns of identiﬁed recombinant pol gene sequences. The region encoding PR, RT, and IN are shown in white boxes on top whereas identiﬁed recombinants are
shown below. Sequences derived from subtype A HIV-1 EF (GenBank EF545108) and FJ (Genbank FJ864679) are shown as black and gray boxes, respectively. Nucleotide 0 in
the scale corresponds to the nucleotide number 2318 in both EF and FJ sequences. Locations of cPPT and the G-rich region hypothesized to be form the G-quartet are
indicated. Open diamonds indicate positions of mutations that confer resistance to anti-viral drugs. Three black squares located in PR, RT, and IN denote amino acid I84, Q151,
and Q148, respectively, which when mutated can confer resistance to antiviral inhibitors.
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originated from different parents (Table 3). Additionally, 47 of the
58 recombinants had crossover events between Q151 of RT and
Q148 of IN. The result of the frequent recombination is that these
two alleles appear to be near equilibrium: in 30 recombinants, the
two alleles came from the same parent, and in 28 recombinants
the two alleles came from different parents (Table 3). These
analyses showed that if recombination occurred between two
variants, one with a drug-resistance mutation in I84 of PR and
the other at Q151 of RT, 26% of the recombinants will have one
allele from one parental and the other from another parental virus.
Thus, 13% of the recombinants will have two wild-type alleles and
13% of the recombinants will have both drug-resistance alleles and
confer dual-drug resistance. This assortment becomes even more
efﬁcient when the distance between alleles is increased. For
example, the sites that encode Q151 in RT and Q148 in IN assort
randomly; thus, if recombination occurs between two viruses each
carrying one of the mutations, 25% of the recombinants will have
both drug-resistance mutations and become dually resistant. Thus,
the high recombination potential of subtype A HIV-1 allows the
generation of dual or multi-drug resistant viruses and can com-
promise the effectiveness of the treatment regimen.
It was proposed that the G-rich regions downstream from the
cPPT can form G-quartets, facilitating interactions between the
two copackaged RNAs, and increasing recombination events
(Piekna-Przybylska et al., 2013). However, in our study the higher
recombination rates were not detected at the proposed G-quartet.
The cPPT and the proposed G-quartet reside between two poly-
morphic sites that are 107 nt apart, which is the longest distance
between two polymorphic sites in our target sequences (Fig. 3).
Although unlikely, we cannot rule out the possibility that the
crossover frequency is exceedingly uneven within the 107-nt
region; because we average out the crossover events detected
over the 107-nt region, a localized high recombination rate can be
diluted out by lower rates in the neighboring region. Further
experimentation is required to examine this possibility.
Materials and methods
Plasmid construction
Sequences based on two subtype A isolates of HIV-1 deposited
in GenBank, EF545108 from Moscow (Thomson et al., 2007) and
FJ864679 from St. Petersburg (Galkin et al., 2012), were synthe-
sized for this study (GENEWIZ). These sequences contain portions
of the viral genome from the primer binding site to nt 5127 in the
pol gene (corresponding to NL4-3 numbering; GenBank
AF324493) and were used to replace the corresponding sequences
of the previously described, NL4-3-based vectors H0 and T6
(Rhodes et al., 2005) using KasI and NdeI restriction enzyme sites
to generate EF-H0 and FJ-T6, respectively. The resulting EF-H0 and
FJ-T6 vectors express Gag/Gag-Pol from subtype A HIV-1. H0
encodes a mouse heat stable antigen (hsa) gene, whereas T6
encodes a mouse thy-1 (thy) gene.
Cell culture, DNA transfections, infections and ﬂow cytometry analysis
The human embryonic kidney cell line 293T and its derivatives
were maintained in Dulbecco's modiﬁed Eagle's medium (CellGro)
supplemented with 5% fetal calf serum (HyClone), 5% calf serum
(HyClone), penicillin (50 U/ml; Gibco), and streptomycin (50 U/ml;
Gibco). The human T cell line Hut/R5, derived from Hut78 to
express chemokine receptor CCR5 (Wu et al., 2002) was main-
tained in RPMI medium (CellGro) supplemented with 10% fetal calf
serum, penicillin (50 U/ml), streptomycin (50 U/ml), 1 μg/ml of
puromycin and 500 μg/ml G418. All cultured cells were main-
tained in humidiﬁed 37 1C incubators with 5% CO2.
DNA transfections were performed using TransIT LT1 reagent
(Mirus) according to the manufacturer's instructions. Viral super-
natants were harvested 48 h post-transfection, clariﬁed through a
0.45-μm-pore size ﬁlter to remove cellular debris, and either used
immediately or stored at 80 1C prior to infection. To detect
marker gene expression, cells were stained with phycoerythrin-
conjugated α-HSA antibody (Becton Dickinson Biosciences) and
allophycocyanin-conjugated α-Thy1.2 antibody (eBioscience) at
0.4 μg/ml and 2.0 μg/ml, respectively. Flow cytometry analyses
were performed on a FACSCalibur system (BD Biosciences)
whereas cell sorting was performed on an ARIA II system (BD
Biosciences). Flow cytometry data was analyzed using FlowJo
software (Tree Star).
Producer cells were generated as follows: viral stocks were
generated by co-transfecting into 293T cells HIV-1 plasmid along
with pVSV-G (Yee et al., 1994), which expresses G protein from
vesicular stomatitis virus. Fresh 293T cells were ﬁrst infected with
EF-H0 virus at a multiplicity of infection (MOI) of 0.1, stained with
α-HSA antibody, and HSAþ cells were enriched by cell sorting.
These HSAþ-enriched cells were then infected with FJ-T6 virus at a
MOI of 0.06, stained with both α-HSA and α-Thy1.2 antibodies, and
sorted for expression of HSA and Thy. Dually infected producer
cells were enriched by several rounds of cell sorting so that more
than 97% of the cells were HSAþ and Thyþ .
To determine recombination rates between EF-H0 and FJ-T6
viruses, producer cells were transfected with pIIINL(AD8)env
(Huang et al., 1995), which expresses HIV-1 CCR5-tropic Env.
Viruses were harvested and used to infect target Hut/R5 cells
(Wu et al., 2002) by spinoculation at 1200g for 1 h at 25 1C.
Infected cells were processed and analyzed 72 h post-infection
using ﬂow cytometry. Hut/R5 cells expressing green ﬂuorescent
protein (GFP), thereby containing recombinant proviruses, were
repeatedly sorted until more than 97% of cells were positive for the
GFP signal. Each pool of GFPþ cells contained 41.5105 inde-
pendent infection events.
Viral DNA isolation, single-genome sequencing and sequence analysis
Genomic DNA was isolated from the sorted GFPþ cell pools
using a QIAamp DNA Blood Mini kit (Qiagen). Single-genome
ampliﬁcation was performed by serially diluting genomic DNA in
96-well plates to identify a dilution at which PCR-positive wells
constituted less than 25% of the total number of reactions. At this
dilution, most wells contain amplicons derived from a single DNA
molecule. PCR ampliﬁcation was performed in the presence of 1
High Fidelity Platinum PCR buffer, 2 mM MgSO4, 0.2 mM of each
deoxynucleoside triphosphate, 0.2 mM of each primer, and
0.025 U/μl Platinum Taq High Fidelity polymerase (Invitrogen) in
a 20-μl reaction. First round PCR primers included sense primer
HIV-A GagF1 50-GTG GCA AAG AAG GAC ACC TAG-30 and antisense
primer HIV-A VifR1 50-GTC GAC ACC CAA TTC TGA AAT G-30. PCR
Table 3
The distribution of three sites among recombinants in one round of HIV-1
replication.
Origin of the two
alleles
Recombination between the two
markers
Same
parents
Different
parents
Recombination
not observed
Recombination
observed
PR I84 to RT Q151
(0.5 kb)
43 15 39 19
RT Q151 to IN
Q148 (1.7 kb)
30 28 11 47
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was performed with the following parameters: 1 cycle of 94 1C for
2 min, 35 cycles of a denaturing step of 94 1C for 15 s, an annealing
step of 55 1C for 30 s, and an extension step of 68 1C for 4 min,
followed by a ﬁnal extension of 68 1C for 10 min. Next, 1 μl from ﬁrst-
round PCR product was added to a second-round PCR reaction that
included the sense primer HIV-A GagF2 50-GGC TGT TGG AAA TGT
GGA AAGG-30 and antisense primer HIV-A VifR2 50-ATG GCT TCC AAT
CCC ATA TGA TG-30. The second-round PCR reaction was performed
under the same conditions used for ﬁrst-round PCR, but with a total of
45 cycles. All PCR procedures were performed under PCR clean room
conditions using procedural safeguards against sample contamination,
including prealiquoting of all reagents, use of dedicated equipment,
and physical separation of sample processing from pre- and post-PCR
ampliﬁcation steps. Correctly sized amplicons were directly sequenced
by cycle-sequencing using BigDye terminator chemistry and protocols
recommended by the manufacturer (Applied Biosystems). Individual
sequence fragments for each amplicon were assembled and edited
using Sequencher (Gene Codes). Inspection of individual chromato-
grams allowed for the conﬁrmation that amplicons were derived from
a single viral template. The absence of mixed bases at each nucleotide
position throughout the entire amplicon was taken as evidence of
single-genome sequencing from a single DNA template. This quality
control measure allowed us to exclude from the analysis amplicons
that resulted from PCR-generated in vitro recombination events or Taq
polymerase errors and to obtain individual sequences that proportio-
nately represent those found in the infected cells.
Statistical analysis
To examine the patterns of distribution of crossover junctions in
the pol gene, data were analyzed with standard regression analysis,
loglinear modeling techniques, contingency table analysis, and
related methods. Tables of counts of the numbers of crossovers
and of counts of nucleotides separating the crossovers at multiple
junctures were subjected to tests for homogeneity, i.e., indepen-
dence (Agresti, 1990). In particular, loglinear analyses were per-
formed to test whether the numbers of crossovers observed in the
pol gene were proportional to the distances between the poly-
morphic sites. Probability values less than 0.05 (po0.05 ) were
considered signiﬁcant.
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